In PTEN knock-in mice harboring two cancer-associated PTEN mutations, PTENC124S and PTENG129E inhibit the PTEN lipid-phosphatase activity in a dominant negative manner, leading to increased activity of PI3K signaling and tumorigenesis [20]. The gene discussed is PIK3CB; the disease is cancer.